STAT

Measles outbreaks put U.S. at risk of losing prized ‘elimination’ status

If measles outbreaks continue, the U.S. could join Venezuela and Brazil as the only countries in the Americas where the disease is considered endemic.
A flyer educating parents about measles is displayed at a pediatrics clinic in Greenbrae, Calif.

With two large and still growing outbreaks in New York pushing the country’s measles count to a quarter-century high, public health officials are starting to grapple with an unpleasant prospect.

The Rockland County and Brooklyn outbreaks have dragged on for eight months. If transmission from either of those outbreaks continues until late September, the United States will likely lose a hard-fought and prized status — that of a country deemed to have “eliminated” measles.

And if that happens — Venezuela and Brazil are the only other countries in the Americas where measles is considered endemic, or constantly circulating — the implications could be profound,

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks